scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will present at the 10th Annual SVB Leerink Global Healthcare Conference on February 24 at 11:20 EDT. The company focuses on optimizing infused therapies to enhance patient care and reduce healthcare costs, particularly for heart failure and infectious diseases. A live webcast of the presentation will be available on their website. For more details, visit scpharmaceuticals.com.

BURLINGTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 10^th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24 at 11:20 EDT.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When is scPharmaceuticals scheduled to present at the SVB Leerink Global Healthcare Conference?

scPharmaceuticals is scheduled to present on February 24 at 11:20 EDT.

Who will represent scPharmaceuticals at the conference?

CEO John Tucker will represent scPharmaceuticals at the conference.

Where can I watch the scPharmaceuticals presentation live?

The live webcast can be accessed on the Investor Relations section of scPharmaceuticals' website.

What is the focus of scPharmaceuticals' products?

scPharmaceuticals focuses on optimizing the delivery of infused therapies to improve patient care and reduce healthcare costs.

What conditions do scPharmaceuticals' lead programs target?

Their lead programs target heart failure and infectious diseases.